| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
H3.3 histone A | 0.559 | 0.692 | 0.12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2016 | 2016 | ||||||||
|
H19/IGF2 imprinting control region | 0.631 | 0.615 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 2C | 0.527 | 0.654 | 0.40 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
KCNQ1 opposite strand/antisense transcript 1 | 0.534 | 0.731 |
|
disease | 0.100 | None | 0 | 0 | ||||||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1996 | 2019 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1997 | 2017 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2005 | 2017 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2008 | 2019 | ||||||||
|
melanocortin 2 receptor | 0.582 | 0.654 | 3.1E-04 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1998 | 2004 | ||||||||
|
microRNA 483 | 0.537 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2019 | |||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1997 | 2005 | ||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
nuclear receptor subfamily 0 group B member 1 | 0.494 | 0.808 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1995 | 2008 | ||||||||
|
BMS1 ribosome biogenesis factor | 0.499 | 0.846 | 1.8E-04 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 | ||||||||
|
keratin 5 | 0.512 | 0.731 | 0.64 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2018 | ||||||||
|
inhibin subunit alpha | 0.578 | 0.615 | 6.5E-03 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2000 | 2014 | ||||||||
|
transcription factor 21 | 0.537 | 0.692 | 0.83 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2017 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2003 | 2009 | ||||||||
|
insulin like growth factor binding protein 2 | 0.478 | 0.769 | 0.12 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2000 | 2007 | ||||||||
|
solute carrier family 12 member 7 | 0.769 | 0.385 | 1.4E-17 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 |